Shawn Novick
Co-Chair; IABS
Mats Wellin
Co-Chair; Swedish Medical Products Agency
Svein Rune Andersen
Norwegian Medicines Agency
Karoline Bechthold-Peters
Novartis
Cristiana Campa
GSK Vaccines
Andrew Chang
Novonordisk
Markus Goese
Roche
Melody Gossage
Eli Lilly and Compan
Emily Jing
FDA - CDER
Mourad Mellal
Catalent
Laurent Mallet
EDQM
Barbara Rellahan
Amgen
Tim Schofield
IABS
Karin Sewerin
BioPharmaLinx AB
Dean Smith
Health Canada
Tami Wu
Seagen

Confirmed Speakers - Session / Breakout co-Chairs – Facilitators

Sean Barry
Health Products Regulatory Authority (HPRA), Ireland
Karoline Bechtold-Peters
Novartis
Isabelle Bekeredjian-Ding
Paul-Ehrlich-Institut (PEI)
Koen Brusselmans
Sciensano
Kelley Burridge
Food & Drug administraton (FDA)
Cristiana Campa
GSK Vaccines
Andrew Chang
Novo Nordisk
Emmanuelle Charton
The European Directorate for the Quality of Medicines & HealthCare (EDQM)
See the Biosketch
Ximeng You Dow
MSD
Elena X. Fragpane
GSK Vaccines
See the Biosketch See the Abstract
George Klein
Amgen
Carol Krantz
Seagen
Philip Krause
Laurent Mallet
The European Directorate for the Quality of Medicines & HealthCare (EDQM)
Roger Nosal
Shawn Novick
IABS
Barbara Rellahan
Amgen
Patrice Riou
Sanofi
Tim Schofield
CMC Sciences
Karin Sewerin
BioPharmaLinx AB
Jayda Siggers
Health Canada
See the Biosketch
Dean Smith
Health Canada

The e-Book will be available soon!

The Meeting Slides will be available soon!

The International Alliance for Biological Standardization (IABS) is an independent, non-profit scientific Alliance, governed by Articles 60-79 of the Swiss Civil code and by its Constitution. Its office is located in Geneva (Switzerland). IABS has members in over 50 countries.

Officers

Mission

The mission of the Alliance which is related to the scientific and medical advancement of Biologicals, includes :

  • To host conferences and workshops, facilitate communication, and develop consensus on key contemporary issues related to biologicals among those who discover, develop, produce and regulate biological products for human and animal health
  • To foster evidence-based Science as the standard for improving and ensuring the quality and the safety of biological products
  • To share scientific advancements and innovative regulatory solutions through our journal “Biologicals”.

Publications

Reports and proceedings of IABS conferences and workshops appear in its journal Biologicals, published by Elsevier.

Membership Benefits

  • Affiliations with a global community of recognized experts
  • Exclusive access to archived information from scientific events (library of speaker presentations, conclusions and recommendations)
  • Reduced fees for a subscription to the journal Biologicals
  • Voting rights for matters discussed during the Biennial IABS General Assembly (Elections, Constitutional changes)

For more information on how to become a member of IABS, please visit: www.iabs.org